Evidence map›Paper›PMID 38085770›Full record

ArticleJournal of the American College of Surgeons2023

Association of High-Deductible Health Plans and Time to Surgery for Breast and Colon Cancer.

Clifford C Sheckter, Danielle H Rochlin, Robyn Rubenstein, Meghana G Shamsunder, Arden M Morris, Todd H Wagner, Evan Matros

Open access · greenAbstract read
In one paragraph

Article in Journal of the American College of Surgeons, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Clifford C SheckterFrom the Division of Plastic and Reconstructive Surgery (Sheckter), Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
Danielle H Rochlinthe Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Rochlin, Rubenstein, Shamsunder, Matros).
Robyn Rubensteinthe Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Rochlin, Rubenstein, Shamsunder, Matros).
Meghana G Shamsunderthe Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Rochlin, Rubenstein, Shamsunder, Matros).
Arden M MorrisS-SPIRE Center (Sheckter, Morris, Wagner), Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
Todd H WagnerS-SPIRE Center (Sheckter, Morris, Wagner), Department of Surgery, Stanford University School of Medicine, Palo Alto, California.
Evan Matrosthe Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York (Rochlin, Rubenstein, Shamsunder, Matros).
Stanford University · USAgency for Healthcare Research and Quality · USNational Center for Advancing Translational Sciences · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Spectrum Stanford Center for clinical and Translational Research and EducationUL1TR001085 · NCATS · STANFORD UNIVERSITY · PI CULLEN, MARK RICHARD, GREENBERG, HARRY BERNARD · 2013 to 2017
$37.1M
Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Transforming health equity rhetoric to rigor: Development and validation of a novel measure assessing health equity in implementation of health interventionsP50DA054072 · NIDA · STANFORD UNIVERSITY · PI Mark P McGovern · 2022 to 2026
$18.1M
Institutional Career Development Core (KL2)KL2TR003143 · NCATS · STANFORD UNIVERSITY · PI ASCH, STEVEN M. · 2019 to 2023
$8.7M
Stagewise Implementation-To-Target- Medications for Addiction Treatment (SITT-MAT)R01DA052975 · NIDA · STANFORD UNIVERSITY · PI FORD, JAMES H, MCGOVERN, MARK P · 2021 to 2025
$3.3M
Reducing Disparities for the Uninsured: Identifying Opportunities for Improved Coverage Through Emergency Medicaid ProgramsR21MD016472 · NIMHD · STANFORD UNIVERSITY · PI KNOWLTON, LISA MARIE · 2021 to 2022
$434k
AHRQ HHS R01 HS026207NCATS NIH HHS KL2 TR003143NCATS NIH HHS UL1 TR001085NCI NIH HHS P30 CA008748NIDA NIH HHS P50 DA054072NIDA NIH HHS R01 DA052975NIDA NIH HHS UG1 DA015815NIMHD NIH HHS R21 MD016472
6 · The paper itself

Abstract

backgroundHigh-deductible health plans (HDHPs) have been shown to delay timing of breast and colon cancer screening, although the relationship to the timing of cancer surgery is unknown. The objective of this study was to characterize timing of surgery for breast and colon cancer patients undergoing cancer operations following routine screening. STUDY

designData from the IBM MarketScan Commercial Claims Database from 2007 to 2016 were queried to identify patients who underwent screening mammogram and/or colonoscopy. The calendar quarters of screening and surgery were analyzed with ordinal logistic regression. The time from screening to surgery (time to surgery, TTS) was evaluated using a Cox proportional hazard function.

resultsAmong 32,562,751 patients who had screening mammograms, 0.7% underwent breast cancer surgery within the following year. Among 9,325,238 patients who had screening colonoscopies, 0.9% were followed by colon cancer surgery within a year. The odds of screening (OR 1.146 for mammogram, 1.272 for colonoscopy; p < 0.001) and surgery (OR 1.120 for breast surgery, 1.219 for colon surgery; p < 0.001) increased each quarter for HDHPs compared to low-deductible health plans. Enrollment in an HDHP was not associated with a difference in TTS. Screening in Q3 or Q4 was associated with shorter TTS compared to screening in Q1 (hazard ratio 1.061 and 1.046, respectively; p < 0.001).

conclusionsHDHPs were associated with delays in screening and surgery. However, HDHPs were not associated with delays in TTS. Interventions to improve cancer care outcomes in the HDHP population should concentrate on reducing barriers to timely screening.

Indexed as

Breast NeoplasmsColonic NeoplasmsDeductibles and CoinsuranceFemaleHumansMammography

Identifiers

PMID38085770
PMCPMC11585011
OpenAlexW4385843591

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.